In Segment A, individuals will acquire various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Further members will probably be enrolled for the discovered monotherapy dosign regimen. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "include-on" therapy. In https://davidh554ufp7.wikijm.com/user